Dr. Jia Lin Yang
University of New South Wales, Australia



2010 Director, University of New South Wales, Australia

2008-present Associate Professor, University of New South Wales, Australia

2001-present Senior Research Fellow (Senior Lecturer), University of New South Wales, Australia

2001-present Research Director, Surgical Oncology Research Group, Australia

Publications (Selected)

  1. Yang JL. (1992). Etiology of Sjogren's syndrome, in APLAR Rheumatology 1992 eds by Nasution AR, Darmawan J and Isbagio H. New York, Churchill Livingstone, pp203-206.
  2. Berney CR, Fisher RJ, Yang J-L, Russell PJ, Crowe PJ (2002). Protein Markers in colorectal cancer: Predictors of liver metastasis. In T., Eberlein, et al. (eds), 2000 Year Book: (4) Surgery. St. Louis, Mosby-Year Book, Inc. 2000, p24.
  3. Walsh WR, Yu Y, Yang J-L, Hocking R, Chapman-Sheath P, Bruce W (2002). Biology and Biomechanics of Fracture Healing. In YH An ed. Internal Fixation in Osteoporotic Bone. Thieme Medical Publishers: New York, pp22-39.
  4. Yu Y, Chen JB, Yang J-L, Walsh WR (2003). In vivo assessment of gamma irradiated bone: osteoconductivity and osteoinductivity. In GO Phillips ed. Advance in Tissue Banking (Vol. 7), World Scientific: New Jersey, pp321-337.
  5. Yang JL, Yu Y (2006). Cancer, in Akay M Ed. The Wiley Encyclopedia of Biomedical Engineering. John Wiley & Sons Inc.
  6. Luk f, Yu Y, Dong H-T, Walsh WR, Yang J-L. New gene groups associated with dissimilar osteoblastic differentiation are linked to osteosarcomagenesis. Cancer Genomics & Proteomics, 2011 in press.
  7. Hopkins A, Crowe PJ, Yang JL. Effect of Type 1 Insulin-Like Growth Factor Receptor Targeted Therapy on Chemotherapy in Human Cancer and the Mechanisms Involved. J Cancer Res Clin Oncol, 2010; 136(5): 639-650. DOI: 10.1007/s00432-010-0792-0.
  8. Expression of Epidermal Growth Factor Receptor in Laryngeal Squamous Cell Carcinoma Index Tumors Correlates with Diagnosis of Second Primary Tumors of the Upper Aero-Digestive Tract. Ann Surg Oncol. 2009 Oct;16(10):2888-94. DOI 10.1245/s10434-009-0649-4.
  9. Zahorowska B, Crowe PJ, Yang JL. Combined therapies for cancer: a review of EGFR targeted monotherapy and combination treatment with other drugs. J Cancer Res Clin Oncol. 2009; 135:1137-48. DOI: 10.1007/s00432-009-0622-4.
  10. Farhadieh R, Smee R, Ow K, Yang J-L, Crouch R, Russell PJ. p33ING1b expression is associated with lymph node metastasis in oral squamous cell carcinoma. Iranian Journal of Medical Science, 2009. Correlation between p33ING1b Cytoplasmic Transfer and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. Iran J Med Sci 2008; 33(1): 27-32.
  11. Yang JL, Qu XJ, Yu Y, Kohn EC, Friedlander ML. Selective sensitivity to carboxyamidotriazole by human cancer cell lines with DNA mismatch repair deficiency. Int J Cancer 2008, 123:258-263 (FAST TRACK Article).
  12. Yang JL, Qu XJ, Hayes VM, Brenner PC, Russell PJ, Goldstein D. Erlotinib (OSI-774) inhibition of transitional cell carcinoma of bladder cell line growth is enhanced by interferon-alpha. Br J Urol International 2007, 99:1539-1545.
  13. Skalicky SE, Ow K, Hannan M, Russell PJ, Crowe PJ, Yang JL. p53 expression is associated with malignant potential in xenograft tissues of a fibrosarcoma mouse model Anticancer Res 2007, 27:973-978.
  14. Mai CT, Choo E, Yang JL, Cooke B, Dumitru D, Lewis CR, Lonergan D. Regional radiotherapy may improve outcomes in patients with early stage breast cancer undergoing breast conservation therapy. Anticancer Res 2007; 27: 647-52.
  15. Yang JL, Crowe PJ. Targeted therapy in soft tissue sarcomas. J Surg Oncol 2007;95(3):183-184.
  16. Chen JB, Yu Y, Yang JL, Morgan DA, Walsh WR. BMP-7 and CBFA1 in allograft bone in vivo bone formation and the influence of gamma-irradiation. J Biomed Mater Res 2007;80A(2):435-43.
  17. Yang JL. Hannan MT. Russell PJ. Crowe PJ. Expression of HER1/EGFR protein in human soft tissue sarcomas. Eur J Surg Oncol 2006; 32(4):466-8.
  18. Yu Y, Chen JB, Yang JL, Morgen DAF, Walsh WR. Evaluation of irradiated human bone in nude rat. Key Eng Mat 2005;288-289:269-272.
  19. Mack LA, Crowe PJ, Yang JL, Schachar NS, Morris M, Kurien E, Temple CLF, Lindsay RL, Magi E, DeHaas WG, Temple WJ. Preoperative chemoradiotherapy (modified Eilber Protocol) provides maximum local control and minimal morbidity in patients with soft tissue sarcoma. Ann Surg Onc 2005;12(8):646-653.
  20. Yang JL, Qu XJ, Russell PJ,Goldstein D, Interferon-alpha promotes the antiproliferative effect of gefitininb on human cancer cell lines. Oncology 2005;69:224-238.
  21. Yang J-L, Qu X-J, Russell PJ, Goldstein D. Interferon-alpha promotes the anti-proliferative effect of erlotinib (OSI-774) on human colon cancer cell lines. Cancer Letters 2005;225:61-74.
  22. Yu Y, Harris RI, Yang J-L, Anderson HC, Walsh WR. Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines. J Biomed Mater Res 2004;70A:122-128.